ImClone Investigational Site

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 5 studies all time

What they study most

Adenocarcinoma, Breast Cancer, Colon Cancer, Gastric Cancer, Non-Small Cell Lung Cancer, Rectal Cancer

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma — Completed
• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• A Study of Ramucirumab or Icrucumab in Colorectal Cancer — Completed
• A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed